

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 4.25944247 |
| 2 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.18842503 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.12478447 |
| 4 | lysine catabolic process (GO:0006554) | 4.06694326 |
| 5 | lysine metabolic process (GO:0006553) | 4.06694326 |
| 6 | protein retention in ER lumen (GO:0006621) | 4.02475207 |
| 7 | phosphate ion transport (GO:0006817) | 3.77621853 |
| 8 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.68617916 |
| 9 | drug transmembrane transport (GO:0006855) | 3.56739946 |
| 10 | phosphate ion transmembrane transport (GO:0035435) | 3.53279321 |
| 11 | activation of Rac GTPase activity (GO:0032863) | 3.48231869 |
| 12 | drug catabolic process (GO:0042737) | 3.47071566 |
| 13 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.40194220 |
| 14 | proline biosynthetic process (GO:0006561) | 3.28533754 |
| 15 | actin filament depolymerization (GO:0030042) | 3.28351348 |
| 16 | regulation of cholesterol homeostasis (GO:2000188) | 3.24008617 |
| 17 | glucose 6-phosphate metabolic process (GO:0051156) | 3.21343017 |
| 18 | * cell communication involved in cardiac conduction (GO:0086065) | 3.17420856 |
| 19 | * sodium ion export (GO:0071436) | 3.16658493 |
| 20 | * cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.16041112 |
| 21 | intestinal absorption (GO:0050892) | 3.15297033 |
| 22 | synaptic vesicle maturation (GO:0016188) | 3.02815886 |
| 23 | drug transport (GO:0015893) | 3.01463741 |
| 24 | tricarboxylic acid metabolic process (GO:0072350) | 3.00200744 |
| 25 | protein localization to endosome (GO:0036010) | 2.98794964 |
| 26 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.97896302 |
| 27 | exogenous drug catabolic process (GO:0042738) | 2.95773767 |
| 28 | plasma membrane repair (GO:0001778) | 2.95674599 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 2.94698096 |
| 30 | cell-substrate adherens junction assembly (GO:0007045) | 2.93783374 |
| 31 | focal adhesion assembly (GO:0048041) | 2.93783374 |
| 32 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.92224954 |
| 33 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.90808459 |
| 34 | locomotory exploration behavior (GO:0035641) | 2.88010493 |
| 35 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87922416 |
| 36 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.81820922 |
| 37 | NADH metabolic process (GO:0006734) | 2.80499794 |
| 38 | embryonic process involved in female pregnancy (GO:0060136) | 2.80391363 |
| 39 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.78918233 |
| 40 | renal absorption (GO:0070293) | 2.78880259 |
| 41 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.78634642 |
| 42 | surfactant homeostasis (GO:0043129) | 2.77857706 |
| 43 | layer formation in cerebral cortex (GO:0021819) | 2.77211955 |
| 44 | negative regulation of fatty acid transport (GO:2000192) | 2.77073035 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 2.76618281 |
| 46 | quaternary ammonium group transport (GO:0015697) | 2.76300204 |
| 47 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.76144835 |
| 48 | skin morphogenesis (GO:0043589) | 2.76080122 |
| 49 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.74898032 |
| 50 | cell volume homeostasis (GO:0006884) | 2.74238105 |
| 51 | amino-acid betaine transport (GO:0015838) | 2.73485708 |
| 52 | carnitine transport (GO:0015879) | 2.73485708 |
| 53 | 2-oxoglutarate metabolic process (GO:0006103) | 2.73361417 |
| 54 | response to mercury ion (GO:0046689) | 2.72916144 |
| 55 | vesicle coating (GO:0006901) | 2.72905877 |
| 56 | hemidesmosome assembly (GO:0031581) | 2.70870039 |
| 57 | activation of protein kinase A activity (GO:0034199) | 2.69948065 |
| 58 | activation of MAPKKK activity (GO:0000185) | 2.69942509 |
| 59 | amino acid import (GO:0043090) | 2.69111632 |
| 60 | * cell communication by electrical coupling (GO:0010644) | 2.68866533 |
| 61 | urate metabolic process (GO:0046415) | 2.68344287 |
| 62 | mating behavior (GO:0007617) | 2.67446053 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.67306294 |
| 64 | positive regulation of nuclease activity (GO:0032075) | 2.66337878 |
| 65 | response to parathyroid hormone (GO:0071107) | 2.65561009 |
| 66 | sexual reproduction (GO:0019953) | 2.60374844 |
| 67 | urea cycle (GO:0000050) | 2.59627708 |
| 68 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.59385123 |
| 69 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.59096717 |
| 70 | regulation of bile acid biosynthetic process (GO:0070857) | 2.58126372 |
| 71 | myelin maintenance (GO:0043217) | 2.57936412 |
| 72 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.57422216 |
| 73 | epithelial cell-cell adhesion (GO:0090136) | 2.56834244 |
| 74 | tricarboxylic acid cycle (GO:0006099) | 2.56261543 |
| 75 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.54883886 |
| 76 | adhesion of symbiont to host (GO:0044406) | 2.54628502 |
| 77 | proline transport (GO:0015824) | 2.53906306 |
| 78 | proline metabolic process (GO:0006560) | 2.53742118 |
| 79 | protein-lipid complex assembly (GO:0065005) | 2.53293528 |
| 80 | fructose metabolic process (GO:0006000) | 2.52968635 |
| 81 | negative regulation of sodium ion transport (GO:0010766) | 2.50629975 |
| 82 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.50512063 |
| 83 | cysteine metabolic process (GO:0006534) | 2.50388657 |
| 84 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.49097811 |
| 85 | semaphorin-plexin signaling pathway (GO:0071526) | 2.49024453 |
| 86 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.48914312 |
| 87 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.48881901 |
| 88 | angiotensin maturation (GO:0002003) | 2.48870246 |
| 89 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.47030358 |
| 90 | excretion (GO:0007588) | 2.46886333 |
| 91 | establishment of nucleus localization (GO:0040023) | 2.46090551 |
| 92 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.45364805 |
| 93 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.44560754 |
| 94 | positive regulation of sodium ion transport (GO:0010765) | 2.44478197 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 2.44172014 |
| 96 | intestinal cholesterol absorption (GO:0030299) | 2.44124684 |
| 97 | glycosphingolipid catabolic process (GO:0046479) | 2.43333277 |
| 98 | basement membrane organization (GO:0071711) | 2.42990166 |
| 99 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.42514732 |
| 100 | glutamate secretion (GO:0014047) | 2.41993379 |
| 101 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.41720540 |
| 102 | ER-nucleus signaling pathway (GO:0006984) | 2.40776924 |
| 103 | cellular copper ion homeostasis (GO:0006878) | 2.40654926 |
| 104 | receptor recycling (GO:0001881) | 2.39614779 |
| 105 | regulation of cholesterol metabolic process (GO:0090181) | 2.39368441 |
| 106 | bicarbonate transport (GO:0015701) | 2.39132138 |
| 107 | cell-cell junction maintenance (GO:0045217) | 2.38246668 |
| 108 | regulation of extracellular matrix disassembly (GO:0010715) | 2.38008930 |
| 109 | 4-hydroxyproline metabolic process (GO:0019471) | 2.37949785 |
| 110 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.37407762 |
| 111 | regulation of nuclease activity (GO:0032069) | 2.36923705 |
| 112 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.36806947 |
| 113 | regulation of early endosome to late endosome transport (GO:2000641) | 2.36473005 |
| 114 | endocytic recycling (GO:0032456) | 2.36456679 |
| 115 | cerebellar granule cell differentiation (GO:0021707) | 2.35703277 |
| 116 | macroautophagy (GO:0016236) | 2.33840301 |
| 117 | L-amino acid import (GO:0043092) | 2.33282598 |
| 118 | synaptic vesicle exocytosis (GO:0016079) | 2.33201929 |
| 119 | urea metabolic process (GO:0019627) | 2.32214759 |
| 120 | cardiac conduction (GO:0061337) | 2.31593654 |
| 121 | negative regulation of cell size (GO:0045792) | 2.31487685 |
| 122 | glutamate metabolic process (GO:0006536) | 2.31253582 |
| 123 | stress fiber assembly (GO:0043149) | 2.31142363 |
| 124 | beta-amyloid metabolic process (GO:0050435) | 2.30751221 |
| 125 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.30648682 |
| 126 | modified amino acid transport (GO:0072337) | 2.30421123 |
| 127 | response to epidermal growth factor (GO:0070849) | 2.30168609 |
| 128 | growth hormone receptor signaling pathway (GO:0060396) | 2.29913738 |
| 129 | carnitine shuttle (GO:0006853) | 2.29111415 |
| 130 | short-chain fatty acid metabolic process (GO:0046459) | 2.28402965 |
| 131 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.28287351 |
| 132 | flavonoid metabolic process (GO:0009812) | 2.28243515 |
| 133 | barbed-end actin filament capping (GO:0051016) | 2.28227558 |
| 134 | hypotonic response (GO:0006971) | 2.27926912 |
| 135 | glycolipid catabolic process (GO:0019377) | 2.27763313 |
| 136 | vitamin transmembrane transport (GO:0035461) | 2.27457258 |
| 137 | oxaloacetate metabolic process (GO:0006107) | 2.27425468 |
| 138 | cellular modified amino acid catabolic process (GO:0042219) | 2.27201065 |
| 139 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.26437740 |
| 140 | COPI coating of Golgi vesicle (GO:0048205) | 2.26265457 |
| 141 | Golgi transport vesicle coating (GO:0048200) | 2.26265457 |
| 142 | multicellular organismal water homeostasis (GO:0050891) | 2.25884438 |
| 143 | hormone catabolic process (GO:0042447) | 2.25114975 |
| 144 | apoptotic cell clearance (GO:0043277) | 2.24890611 |
| 145 | regulation of histone H3-K27 methylation (GO:0061085) | 2.24871192 |
| 146 | gap junction assembly (GO:0016264) | 2.24752005 |
| 147 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.24568431 |
| 148 | regulation of p38MAPK cascade (GO:1900744) | 2.24318284 |
| 149 | cellular response to prostaglandin stimulus (GO:0071379) | 2.24276454 |
| 150 | cellular response to reactive nitrogen species (GO:1902170) | 2.24045663 |
| 151 | COPII vesicle coating (GO:0048208) | 2.23966493 |
| 152 | regulation of ARF protein signal transduction (GO:0032012) | 2.23611414 |
| 153 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.21832992 |
| 154 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.21648765 |
| 155 | carnitine transmembrane transport (GO:1902603) | 2.21605273 |
| 156 | * membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.19862885 |
| 157 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.19429419 |
| 158 | homocysteine metabolic process (GO:0050667) | 2.18768648 |
| 159 | cell-substrate junction assembly (GO:0007044) | 2.18350901 |
| 160 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.17779793 |
| 161 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.15652936 |
| 162 | adherens junction assembly (GO:0034333) | 2.14847623 |
| 163 | protein targeting to plasma membrane (GO:0072661) | 2.14827126 |
| 164 | alanine transport (GO:0032328) | 2.14811697 |
| 165 | protein targeting to Golgi (GO:0000042) | 2.13787304 |
| 166 | neuromuscular process controlling balance (GO:0050885) | 2.12547378 |
| 167 | * cellular potassium ion homeostasis (GO:0030007) | 2.10128325 |
| 168 | peptide catabolic process (GO:0043171) | 2.09983115 |
| 169 | actin filament capping (GO:0051693) | 2.09349117 |
| 170 | establishment of protein localization to Golgi (GO:0072600) | 2.09167817 |
| 171 | organic cation transport (GO:0015695) | 2.09124780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.76715835 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.40294840 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39472492 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.35064895 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.29344226 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.28887022 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.08074046 |
| 8 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.01908511 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 1.96298237 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95190794 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.94122049 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91494595 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89854362 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88017644 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87876300 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83962599 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82571323 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82431606 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82276028 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.77572715 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75165689 |
| 22 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73955199 |
| 23 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.73852005 |
| 24 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.73719814 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70673236 |
| 26 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66613661 |
| 27 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65051537 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.64895068 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.61137450 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.56756262 |
| 31 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55198710 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.54818516 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53599040 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.53479778 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51246511 |
| 36 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48186708 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47157793 |
| 38 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44696690 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44239009 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42892117 |
| 41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41723806 |
| 42 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.41669029 |
| 43 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.41418719 |
| 44 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.40123869 |
| 45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.34445482 |
| 46 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.34445482 |
| 47 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.33944130 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33612482 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33048070 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.32823188 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.31789381 |
| 52 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.31653994 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31207649 |
| 54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31025277 |
| 55 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30803490 |
| 56 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28825789 |
| 57 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28464946 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28358849 |
| 59 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27506635 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27423749 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27270338 |
| 62 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26419171 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.26317602 |
| 64 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.26180269 |
| 65 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26113382 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25813003 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.25280085 |
| 68 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.25280085 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24422823 |
| 70 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24094784 |
| 71 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.23713303 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23278156 |
| 73 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.22951029 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22703249 |
| 75 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21935609 |
| 76 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21662829 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21638026 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21210624 |
| 79 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.20636977 |
| 80 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20373057 |
| 81 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19481917 |
| 82 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19072954 |
| 83 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17142908 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15025586 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15000335 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14337544 |
| 87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13403059 |
| 88 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13207023 |
| 89 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13038481 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12876793 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12736325 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11122056 |
| 93 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10563096 |
| 94 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09666769 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08145689 |
| 96 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07805145 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06470014 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05995419 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05268806 |
| 100 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04539186 |
| 101 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04536529 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04236349 |
| 103 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.04209460 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04066358 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03741367 |
| 106 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02942712 |
| 107 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02689290 |
| 108 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02543294 |
| 109 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02415940 |
| 110 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02319478 |
| 111 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.02251876 |
| 112 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01491178 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01322280 |
| 114 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01244121 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00789158 |
| 116 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99827324 |
| 117 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98910652 |
| 118 | * P68_20966046_ChIP-Seq_HELA_Human | 0.98341414 |
| 119 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98089692 |
| 120 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97417180 |
| 121 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.96565618 |
| 122 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96186715 |
| 123 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96175386 |
| 124 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95859164 |
| 125 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95546589 |
| 126 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95279606 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94916821 |
| 128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94916821 |
| 129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94815731 |
| 130 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94020052 |
| 131 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93953315 |
| 132 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93868904 |
| 133 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93282207 |
| 134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92405885 |
| 135 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.90751131 |
| 136 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90674243 |
| 137 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90525738 |
| 138 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89646241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.73222294 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.11552483 |
| 3 | MP0004043_abnormal_pH_regulation | 3.85115577 |
| 4 | MP0005409_darkened_coat_color | 3.53942928 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.76615058 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.67570015 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.56737992 |
| 8 | MP0000678_abnormal_parathyroid_gland | 2.53904915 |
| 9 | MP0004858_abnormal_nervous_system | 2.45557912 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 2.43812301 |
| 11 | MP0003878_abnormal_ear_physiology | 2.43812301 |
| 12 | MP0005451_abnormal_body_composition | 2.41328695 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.34244150 |
| 14 | MP0003283_abnormal_digestive_organ | 2.33853757 |
| 15 | MP0008961_abnormal_basal_metabolism | 2.24362215 |
| 16 | MP0001765_abnormal_ion_homeostasis | 2.17660560 |
| 17 | MP0003252_abnormal_bile_duct | 2.15930059 |
| 18 | MP0005076_abnormal_cell_differentiation | 2.09683798 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.07053253 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.04485078 |
| 21 | MP0005257_abnormal_intraocular_pressure | 2.03824450 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.03247266 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 1.90817074 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.86632779 |
| 25 | MP0005332_abnormal_amino_acid | 1.84835397 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.79382366 |
| 27 | MP0000566_synostosis | 1.75284438 |
| 28 | MP0003329_amyloid_beta_deposits | 1.74343688 |
| 29 | MP0001756_abnormal_urination | 1.71631991 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.69640836 |
| 31 | MP0000751_myopathy | 1.68334436 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.67505869 |
| 33 | MP0003195_calcinosis | 1.66189107 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.66087003 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.65170931 |
| 36 | MP0003045_fibrosis | 1.62908085 |
| 37 | MP0000579_abnormal_nail_morphology | 1.61586252 |
| 38 | MP0004885_abnormal_endolymph | 1.58562286 |
| 39 | MP0009840_abnormal_foam_cell | 1.58490504 |
| 40 | MP0004270_analgesia | 1.57887888 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.57090576 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.55845349 |
| 43 | MP0000537_abnormal_urethra_morphology | 1.55127782 |
| 44 | MP0003091_abnormal_cell_migration | 1.54971062 |
| 45 | MP0008260_abnormal_autophagy | 1.52387323 |
| 46 | MP0003123_paternal_imprinting | 1.48468442 |
| 47 | MP0001849_ear_inflammation | 1.39803861 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.38228598 |
| 49 | MP0001348_abnormal_lacrimal_gland | 1.37537740 |
| 50 | MP0001958_emphysema | 1.33291980 |
| 51 | MP0005501_abnormal_skin_physiology | 1.30246460 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.30219650 |
| 53 | MP0002089_abnormal_postnatal_growth/wei | 1.29885516 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.29462799 |
| 55 | MP0004215_abnormal_myocardial_fiber | 1.28103748 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.27486105 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.24577206 |
| 58 | MP0005423_abnormal_somatic_nervous | 1.23591204 |
| 59 | MP0003879_abnormal_hair_cell | 1.23576841 |
| 60 | MP0000747_muscle_weakness | 1.22711158 |
| 61 | MP0002136_abnormal_kidney_physiology | 1.21715390 |
| 62 | MP0003866_abnormal_defecation | 1.20621668 |
| 63 | MP0005365_abnormal_bile_salt | 1.20061883 |
| 64 | MP0002098_abnormal_vibrissa_morphology | 1.17915595 |
| 65 | MP0004484_altered_response_of | 1.16950388 |
| 66 | MP0000604_amyloidosis | 1.16771346 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.16423195 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.15504555 |
| 69 | MP0005023_abnormal_wound_healing | 1.13294763 |
| 70 | MP0000920_abnormal_myelination | 1.12741706 |
| 71 | MP0000538_abnormal_urinary_bladder | 1.12641023 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.11370628 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.10946169 |
| 74 | MP0003635_abnormal_synaptic_transmissio | 1.10472011 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.10356936 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 1.10223400 |
| 77 | MP0005623_abnormal_meninges_morphology | 1.10151625 |
| 78 | MP0005408_hypopigmentation | 1.09911223 |
| 79 | MP0004947_skin_inflammation | 1.08536983 |
| 80 | MP0004130_abnormal_muscle_cell | 1.08266192 |
| 81 | MP0002896_abnormal_bone_mineralization | 1.06237184 |
| 82 | MP0002822_catalepsy | 1.05778991 |
| 83 | MP0000003_abnormal_adipose_tissue | 1.04870325 |
| 84 | MP0004147_increased_porphyrin_level | 1.03973209 |
| 85 | MP0004233_abnormal_muscle_weight | 1.02584364 |
| 86 | MP0003634_abnormal_glial_cell | 1.02200935 |
| 87 | MP0004087_abnormal_muscle_fiber | 1.02071758 |
| 88 | MP0002060_abnormal_skin_morphology | 1.00844183 |
| 89 | MP0000681_abnormal_thyroid_gland | 1.00173867 |
| 90 | MP0006138_congestive_heart_failure | 1.00087061 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.96612451 |
| 92 | MP0002735_abnormal_chemical_nociception | 0.95411469 |
| 93 | MP0005330_cardiomyopathy | 0.95400869 |
| 94 | MP0003868_abnormal_feces_composition | 0.95286902 |
| 95 | MP0001730_embryonic_growth_arrest | 0.94842234 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.94835531 |
| 97 | MP0005083_abnormal_biliary_tract | 0.94534612 |
| 98 | MP0008569_lethality_at_weaning | 0.93159335 |
| 99 | MP0009672_abnormal_birth_weight | 0.92074700 |
| 100 | MP0003075_altered_response_to | 0.91722482 |
| 101 | MP0005165_increased_susceptibility_to | 0.91290965 |
| 102 | MP0000534_abnormal_ureter_morphology | 0.91218867 |
| 103 | MP0000467_abnormal_esophagus_morphology | 0.90937936 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.89932335 |
| 105 | MP0004510_myositis | 0.89680548 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.89670876 |
| 107 | MP0005621_abnormal_cell_physiology | 0.87858501 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.87259000 |
| 109 | MP0005187_abnormal_penis_morphology | 0.87191953 |
| 110 | MP0000462_abnormal_digestive_system | 0.86516005 |
| 111 | MP0002269_muscular_atrophy | 0.86015532 |
| 112 | MP0003690_abnormal_glial_cell | 0.85509357 |
| 113 | MP0002168_other_aberrant_phenotype | 0.84670305 |
| 114 | * MP0002972_abnormal_cardiac_muscle | 0.84623954 |
| 115 | MP0009046_muscle_twitch | 0.84237122 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83208127 |
| 117 | MP0000377_abnormal_hair_follicle | 0.83042667 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.81304433 |
| 119 | MP0004272_abnormal_basement_membrane | 0.80715836 |
| 120 | MP0010678_abnormal_skin_adnexa | 0.79230828 |
| 121 | MP0002118_abnormal_lipid_homeostasis | 0.78903716 |
| 122 | MP0010630_abnormal_cardiac_muscle | 0.78823695 |
| 123 | MP0000569_abnormal_digit_pigmentation | 0.77326202 |
| 124 | MP0000858_altered_metastatic_potential | 0.75965501 |
| 125 | MP0004185_abnormal_adipocyte_glucose | 0.75933158 |
| 126 | MP0002734_abnormal_mechanical_nocicepti | 0.74878883 |
| 127 | MP0000762_abnormal_tongue_morphology | 0.74808169 |
| 128 | MP0005166_decreased_susceptibility_to | 0.74766948 |
| 129 | MP0003172_abnormal_lysosome_physiology | 0.74751487 |
| 130 | MP0001346_abnormal_lacrimal_gland | 0.73837606 |
| 131 | MP0003646_muscle_fatigue | 0.73664394 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.73595365 |
| 133 | MP0002998_abnormal_bone_remodeling | 0.73065348 |
| 134 | MP0005171_absent_coat_pigmentation | 0.71868662 |
| 135 | MP0002796_impaired_skin_barrier | 0.71819490 |
| 136 | MP0001968_abnormal_touch/_nociception | 0.71515402 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.71086852 |
| 138 | MP0002249_abnormal_larynx_morphology | 0.70954685 |
| 139 | MP0003633_abnormal_nervous_system | 0.70552773 |
| 140 | MP0001664_abnormal_digestion | 0.70263844 |
| 141 | MP0010155_abnormal_intestine_physiology | 0.70203306 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.69810460 |
| 143 | MP0004085_abnormal_heartbeat | 0.67255439 |
| 144 | MP0000627_abnormal_mammary_gland | 0.66829008 |
| 145 | MP0000490_abnormal_crypts_of | 0.65377990 |
| 146 | MP0002086_abnormal_extraembryonic_tissu | 0.63192842 |
| 147 | MP0002064_seizures | 0.60867700 |
| 148 | MP0008874_decreased_physiological_sensi | 0.60822518 |
| 149 | MP0003303_peritoneal_inflammation | 0.60663717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 4.43003324 |
| 2 | Increased circulating renin level (HP:0000848) | 4.38038835 |
| 3 | Metabolic alkalosis (HP:0200114) | 4.34329096 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 4.11170554 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 4.08115707 |
| 6 | Gout (HP:0001997) | 3.92587896 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.28183373 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 3.25198860 |
| 9 | Abnormal urine output (HP:0012590) | 3.18457063 |
| 10 | Polyuria (HP:0000103) | 3.10497714 |
| 11 | Abnormality of renin-angiotensin system (HP:0000847) | 3.09352577 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.08495033 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 3.00300554 |
| 14 | Abnormality of renal excretion (HP:0011036) | 2.97922816 |
| 15 | Ventricular fibrillation (HP:0001663) | 2.97843684 |
| 16 | Hyperaldosteronism (HP:0000859) | 2.97142548 |
| 17 | Hypomagnesemia (HP:0002917) | 2.97100238 |
| 18 | Bundle branch block (HP:0011710) | 2.84356588 |
| 19 | Renal salt wasting (HP:0000127) | 2.77015663 |
| 20 | Hand muscle atrophy (HP:0009130) | 2.76889011 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 2.74501541 |
| 22 | Action tremor (HP:0002345) | 2.72954494 |
| 23 | Dysmetric saccades (HP:0000641) | 2.72401783 |
| 24 | Abnormality of magnesium homeostasis (HP:0004921) | 2.71923609 |
| 25 | Upper limb amyotrophy (HP:0009129) | 2.68839756 |
| 26 | Distal upper limb amyotrophy (HP:0007149) | 2.68839756 |
| 27 | Hyperparathyroidism (HP:0000843) | 2.67554493 |
| 28 | Ketoacidosis (HP:0001993) | 2.66284305 |
| 29 | Alkalosis (HP:0001948) | 2.62678790 |
| 30 | Hyperuricemia (HP:0002149) | 2.60178201 |
| 31 | Increased purine levels (HP:0004368) | 2.60178201 |
| 32 | Hypercalciuria (HP:0002150) | 2.55783538 |
| 33 | Deep venous thrombosis (HP:0002625) | 2.53500168 |
| 34 | Tetany (HP:0001281) | 2.53350924 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 2.48806057 |
| 36 | Hydroxyprolinuria (HP:0003080) | 2.48806057 |
| 37 | Polydipsia (HP:0001959) | 2.45603560 |
| 38 | Abnormal drinking behavior (HP:0030082) | 2.45603560 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 2.44639202 |
| 40 | Hypokalemia (HP:0002900) | 2.43267806 |
| 41 | Sudden death (HP:0001699) | 2.40424901 |
| 42 | Thin bony cortex (HP:0002753) | 2.34652247 |
| 43 | Broad face (HP:0000283) | 2.32263669 |
| 44 | Protrusio acetabuli (HP:0003179) | 2.32163519 |
| 45 | Lymphangioma (HP:0100764) | 2.29482980 |
| 46 | Hyperglycinuria (HP:0003108) | 2.28723621 |
| 47 | Distal lower limb amyotrophy (HP:0008944) | 2.28021040 |
| 48 | Adrenal overactivity (HP:0002717) | 2.27411671 |
| 49 | Obstructive sleep apnea (HP:0002870) | 2.26747339 |
| 50 | Vertebral compression fractures (HP:0002953) | 2.24902104 |
| 51 | Pili torti (HP:0003777) | 2.23305303 |
| 52 | Facial shape deformation (HP:0011334) | 2.23040105 |
| 53 | Potter facies (HP:0002009) | 2.23040105 |
| 54 | Syncope (HP:0001279) | 2.21151558 |
| 55 | Ankyloglossia (HP:0010296) | 2.17602816 |
| 56 | Asymmetry of the thorax (HP:0001555) | 2.16555443 |
| 57 | Abnormality of the lower motor neuron (HP:0002366) | 2.13288801 |
| 58 | Abnormality of potassium homeostasis (HP:0011042) | 2.12801926 |
| 59 | Abnormality of carpal bone ossification (HP:0006257) | 2.12687818 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.10953410 |
| 61 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.10251915 |
| 62 | Ileus (HP:0002595) | 2.08479681 |
| 63 | Abnormality of the salivary glands (HP:0010286) | 2.08405288 |
| 64 | Subacute progressive viral hepatitis (HP:0006572) | 2.06211267 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.03056601 |
| 66 | Cholecystitis (HP:0001082) | 2.03056601 |
| 67 | Spinal cord compression (HP:0002176) | 2.00812084 |
| 68 | Neuronal loss in central nervous system (HP:0002529) | 2.00736789 |
| 69 | Growth hormone excess (HP:0000845) | 2.00673476 |
| 70 | Flat acetabular roof (HP:0003180) | 2.00316890 |
| 71 | Cerebral aneurysm (HP:0004944) | 1.99871827 |
| 72 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.99711406 |
| 73 | Focal segmental glomerulosclerosis (HP:0000097) | 1.99589126 |
| 74 | Malnutrition (HP:0004395) | 1.99451246 |
| 75 | Glomerulosclerosis (HP:0000096) | 1.99399644 |
| 76 | Achilles tendon contracture (HP:0001771) | 1.98729632 |
| 77 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.98562887 |
| 78 | Ketosis (HP:0001946) | 1.94808248 |
| 79 | Abnormal ossification of hand bones (HP:0005921) | 1.93955560 |
| 80 | Ventricular arrhythmia (HP:0004308) | 1.93044571 |
| 81 | Hyporeflexia of lower limbs (HP:0002600) | 1.92998846 |
| 82 | Bronchomalacia (HP:0002780) | 1.92497123 |
| 83 | Hyperacusis (HP:0010780) | 1.92496171 |
| 84 | Elfin facies (HP:0004428) | 1.92464735 |
| 85 | Lower limb amyotrophy (HP:0007210) | 1.92120044 |
| 86 | Aplasia involving bones of the extremities (HP:0009825) | 1.92055473 |
| 87 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.92055473 |
| 88 | Aplasia of the phalanges of the hand (HP:0009802) | 1.92055473 |
| 89 | Proximal tubulopathy (HP:0000114) | 1.91556363 |
| 90 | Nephrolithiasis (HP:0000787) | 1.89163363 |
| 91 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89147225 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 1.89021816 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89021816 |
| 94 | Neonatal death (HP:0003811) | 1.88784644 |
| 95 | Ulnar bowing (HP:0003031) | 1.88775571 |
| 96 | Arterial tortuosity (HP:0005116) | 1.87213159 |
| 97 | Premature rupture of membranes (HP:0001788) | 1.86964249 |
| 98 | Advanced eruption of teeth (HP:0006288) | 1.86172350 |
| 99 | Abdominal distention (HP:0003270) | 1.84754128 |
| 100 | Ankle clonus (HP:0011448) | 1.84689436 |
| 101 | J-shaped sella turcica (HP:0002680) | 1.83866263 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 1.83573685 |
| 103 | Myokymia (HP:0002411) | 1.80994492 |
| 104 | Exercise-induced muscle cramps (HP:0003710) | 1.80709143 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 1.78980141 |
| 106 | Relative macrocephaly (HP:0004482) | 1.77447803 |
| 107 | Aneurysm (HP:0002617) | 1.76693541 |
| 108 | Hypotension (HP:0002615) | 1.76680100 |
| 109 | Metaphyseal cupping (HP:0003021) | 1.76644727 |
| 110 | Abnormality of oral frenula (HP:0000190) | 1.76383358 |
| 111 | Broad metatarsal (HP:0001783) | 1.76328298 |
| 112 | Termporal pattern (HP:0011008) | 1.75709620 |
| 113 | Insidious onset (HP:0003587) | 1.75709620 |
| 114 | Visual hallucinations (HP:0002367) | 1.75550880 |
| 115 | Rectal prolapse (HP:0002035) | 1.75173377 |
| 116 | Visceral angiomatosis (HP:0100761) | 1.74760999 |
| 117 | Abnormality of glycine metabolism (HP:0010895) | 1.73865331 |
| 118 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.73865331 |
| 119 | Alacrima (HP:0000522) | 1.73584401 |
| 120 | Hyperphosphatemia (HP:0002905) | 1.72719856 |
| 121 | Myoglobinuria (HP:0002913) | 1.71644057 |
| 122 | Long toe (HP:0010511) | 1.70822666 |
| 123 | Hemiplegia (HP:0002301) | 1.69920459 |
| 124 | Skin nodule (HP:0200036) | 1.68348841 |
| 125 | Distal sensory impairment (HP:0002936) | 1.67991264 |
| 126 | Interstitial pulmonary disease (HP:0006530) | 1.67788237 |
| 127 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.67630298 |
| 128 | Short nail (HP:0001799) | 1.67578310 |
| 129 | Dehydration (HP:0001944) | 1.67040820 |
| 130 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.66101152 |
| 131 | Lower limb asymmetry (HP:0100559) | 1.65975892 |
| 132 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65485339 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.65485339 |
| 134 | Late onset (HP:0003584) | 1.64721687 |
| 135 | Annular pancreas (HP:0001734) | 1.64669822 |
| 136 | Peripheral hypomyelination (HP:0007182) | 1.63878037 |
| 137 | Resting tremor (HP:0002322) | 1.63020380 |
| 138 | Enlarged penis (HP:0000040) | 1.63010196 |
| 139 | Shallow orbits (HP:0000586) | 1.62935012 |
| 140 | Abnormal tarsal ossification (HP:0008369) | 1.62810352 |
| 141 | Ventricular tachycardia (HP:0004756) | 1.62517680 |
| 142 | Goiter (HP:0000853) | 1.62216859 |
| 143 | Prolonged QT interval (HP:0001657) | 1.62042580 |
| 144 | Hemangiomatosis (HP:0007461) | 1.61749086 |
| 145 | Heart block (HP:0012722) | 1.61639640 |
| 146 | Neonatal onset (HP:0003623) | 1.61236999 |
| 147 | Decreased circulating renin level (HP:0003351) | 1.60641270 |
| 148 | Palpitations (HP:0001962) | 1.60454546 |
| 149 | Abnormal hair laboratory examination (HP:0003328) | 1.60451235 |
| 150 | Decreased motor nerve conduction velocity (HP:0003431) | 1.59942744 |
| 151 | Abnormality of sodium homeostasis (HP:0010931) | 1.59840031 |
| 152 | Depression (HP:0000716) | 1.59479230 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.59278108 |
| 154 | Abnormality of the gastric mucosa (HP:0004295) | 1.59021672 |
| 155 | Insomnia (HP:0100785) | 1.58057801 |
| 156 | Hyperammonemia (HP:0001987) | 1.57977934 |
| 157 | Disproportionate tall stature (HP:0001519) | 1.57788338 |
| 158 | Hypercortisolism (HP:0001578) | 1.57680794 |
| 159 | Xanthomatosis (HP:0000991) | 1.57505314 |
| 160 | Germ cell neoplasia (HP:0100728) | 1.56669515 |
| 161 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.56643768 |
| 162 | Increased CSF protein (HP:0002922) | 1.56404077 |
| 163 | Vascular tortuosity (HP:0004948) | 1.55684331 |
| 164 | Abnormality of complement system (HP:0005339) | 1.55549232 |
| 165 | Axonal loss (HP:0003447) | 1.55475506 |
| 166 | Apathy (HP:0000741) | 1.55137021 |
| 167 | Bone pain (HP:0002653) | 1.55102241 |
| 168 | Hypophosphatemia (HP:0002148) | 1.54342841 |
| 169 | Hammertoe (HP:0001765) | 1.54316999 |
| 170 | Back pain (HP:0003418) | 1.53206954 |
| 171 | Slow saccadic eye movements (HP:0000514) | 1.50931160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 3.56996178 |
| 2 | TRIB3 | 3.48206010 |
| 3 | LMTK2 | 3.34835560 |
| 4 | RIPK1 | 3.08843090 |
| 5 | PRPF4B | 2.98044650 |
| 6 | PKN2 | 2.84852375 |
| 7 | CDK12 | 2.79130578 |
| 8 | SMG1 | 2.61785237 |
| 9 | MAP3K9 | 2.38245205 |
| 10 | OXSR1 | 2.35504309 |
| 11 | KSR2 | 2.32311412 |
| 12 | WNK3 | 2.31568333 |
| 13 | MST1R | 2.21972746 |
| 14 | MAP3K2 | 2.10617074 |
| 15 | PTK6 | 1.92988005 |
| 16 | IRAK3 | 1.91011754 |
| 17 | NEK1 | 1.71312913 |
| 18 | STK39 | 1.60926565 |
| 19 | FRK | 1.55081678 |
| 20 | PRKD3 | 1.54797498 |
| 21 | WNK1 | 1.54454810 |
| 22 | CAMKK1 | 1.54030165 |
| 23 | TTN | 1.49837057 |
| 24 | EEF2K | 1.49577871 |
| 25 | STK38 | 1.47740000 |
| 26 | NTRK1 | 1.46637635 |
| 27 | PDGFRA | 1.45102188 |
| 28 | MAP3K13 | 1.44956447 |
| 29 | SCYL2 | 1.44608090 |
| 30 | ARAF | 1.43628543 |
| 31 | DAPK2 | 1.42399950 |
| 32 | RET | 1.42300995 |
| 33 | PTK2 | 1.35317290 |
| 34 | EPHB1 | 1.28602701 |
| 35 | ERN1 | 1.27118574 |
| 36 | FER | 1.26572000 |
| 37 | PAK6 | 1.26360012 |
| 38 | TAOK1 | 1.22282300 |
| 39 | NTRK3 | 1.20519942 |
| 40 | BMX | 1.16847634 |
| 41 | MAP3K7 | 1.12809326 |
| 42 | TYRO3 | 1.09965655 |
| 43 | SGK3 | 1.08885549 |
| 44 | MINK1 | 1.05228506 |
| 45 | DMPK | 1.04547973 |
| 46 | LRRK2 | 1.04360748 |
| 47 | MET | 1.03930645 |
| 48 | LATS1 | 1.03646451 |
| 49 | RIPK4 | 1.03373874 |
| 50 | ALK | 0.96966947 |
| 51 | PAK3 | 0.95971773 |
| 52 | MAP3K3 | 0.95966042 |
| 53 | PDK4 | 0.93912300 |
| 54 | PDK3 | 0.93912300 |
| 55 | NEK6 | 0.93573911 |
| 56 | CAMKK2 | 0.92984788 |
| 57 | MAP3K1 | 0.92822170 |
| 58 | FGFR4 | 0.90223776 |
| 59 | PRKG2 | 0.88739838 |
| 60 | DDR2 | 0.86748828 |
| 61 | PRKCH | 0.86133378 |
| 62 | PAK4 | 0.85993366 |
| 63 | MAP3K10 | 0.84535773 |
| 64 | NME2 | 0.84358991 |
| 65 | TAOK2 | 0.81812392 |
| 66 | PDPK1 | 0.80983882 |
| 67 | MAP3K4 | 0.80962925 |
| 68 | EPHA2 | 0.80503755 |
| 69 | SIK1 | 0.80485344 |
| 70 | MAPK11 | 0.78348880 |
| 71 | LATS2 | 0.78120000 |
| 72 | ICK | 0.75953411 |
| 73 | SGK223 | 0.73959576 |
| 74 | SGK494 | 0.73959576 |
| 75 | PDK1 | 0.73508274 |
| 76 | MAP2K2 | 0.72309202 |
| 77 | CDC42BPA | 0.71058712 |
| 78 | PHKG1 | 0.69933203 |
| 79 | PHKG2 | 0.69933203 |
| 80 | CAMK1G | 0.69619538 |
| 81 | MAP2K4 | 0.69372564 |
| 82 | MAP2K1 | 0.67635084 |
| 83 | MARK2 | 0.64382912 |
| 84 | BRAF | 0.60707840 |
| 85 | KSR1 | 0.60347126 |
| 86 | CDK6 | 0.57944413 |
| 87 | PDGFRB | 0.55782538 |
| 88 | UHMK1 | 0.55382513 |
| 89 | STK11 | 0.55048518 |
| 90 | SGK2 | 0.54945388 |
| 91 | CDK15 | 0.54904490 |
| 92 | MAP3K8 | 0.54681166 |
| 93 | DAPK1 | 0.53049780 |
| 94 | CDK5 | 0.52021002 |
| 95 | PRKAA1 | 0.51781391 |
| 96 | FGFR1 | 0.51036175 |
| 97 | CDK18 | 0.50487865 |
| 98 | JAK2 | 0.49699959 |
| 99 | MTOR | 0.49604257 |
| 100 | FGFR3 | 0.49276825 |
| 101 | CDK11A | 0.49087988 |
| 102 | ERBB2 | 0.48727970 |
| 103 | CAMK1D | 0.48382480 |
| 104 | PDK2 | 0.48002536 |
| 105 | PRKD1 | 0.45888015 |
| 106 | EPHB2 | 0.45430780 |
| 107 | TESK2 | 0.45321910 |
| 108 | SIK2 | 0.44739314 |
| 109 | MAPK10 | 0.44507850 |
| 110 | JAK3 | 0.44085366 |
| 111 | PTK2B | 0.44029250 |
| 112 | MAP3K14 | 0.43791745 |
| 113 | MYLK | 0.43207756 |
| 114 | GRK6 | 0.42856653 |
| 115 | CAMK4 | 0.42741237 |
| 116 | RPS6KB2 | 0.42059209 |
| 117 | ROCK1 | 0.41948663 |
| 118 | AKT2 | 0.41771026 |
| 119 | BRD4 | 0.41406740 |
| 120 | IRAK2 | 0.41125074 |
| 121 | PAK2 | 0.39500557 |
| 122 | CDK14 | 0.39104759 |
| 123 | JAK1 | 0.38298630 |
| 124 | CAMK2B | 0.37373205 |
| 125 | SGK1 | 0.36216946 |
| 126 | MAPKAPK3 | 0.35438979 |
| 127 | EPHA4 | 0.35390538 |
| 128 | SRC | 0.35189181 |
| 129 | GSK3A | 0.34796068 |
| 130 | TESK1 | 0.34022285 |
| 131 | RPS6KA2 | 0.33662599 |
| 132 | MAPK12 | 0.33114799 |
| 133 | MATK | 0.32984388 |
| 134 | ROCK2 | 0.31871133 |
| 135 | MAP3K11 | 0.31707828 |
| 136 | NEK9 | 0.30726359 |
| 137 | RAF1 | 0.29537647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.59397729 |
| 2 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.47132419 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18769316 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.15626654 |
| 5 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08478441 |
| 6 | * Bile secretion_Homo sapiens_hsa04976 | 1.93813554 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91603363 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69400403 |
| 9 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.64942940 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55283381 |
| 11 | * Mineral absorption_Homo sapiens_hsa04978 | 1.50258962 |
| 12 | Prion diseases_Homo sapiens_hsa05020 | 1.48972944 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47492402 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46622684 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.46361982 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.42854379 |
| 17 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.41935123 |
| 18 | Thyroid cancer_Homo sapiens_hsa05216 | 1.41340063 |
| 19 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.38968232 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28411289 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26525788 |
| 22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20882377 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.20786612 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20215504 |
| 25 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14748730 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14286969 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.14095767 |
| 28 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.14059419 |
| 29 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 1.13302056 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11922245 |
| 31 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.11356629 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11294550 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11283343 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.10922931 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.10468233 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06236037 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06190531 |
| 38 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04905372 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02753471 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02278693 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00401782 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.00243631 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99828991 |
| 44 | * Salivary secretion_Homo sapiens_hsa04970 | 0.99800262 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99269756 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99166244 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98855724 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97689734 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96805840 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96722538 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95346697 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94640034 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93893253 |
| 54 | * Insulin secretion_Homo sapiens_hsa04911 | 0.93813712 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93226149 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.91629425 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90346725 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.88985347 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88753264 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88706285 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.87623164 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87216576 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.86829560 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85864030 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84542519 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83938911 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82126402 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.81921636 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81169118 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.80254725 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.80216659 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80131495 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79631540 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79268466 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78479674 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.76896336 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76619659 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76426490 |
| 79 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.76033957 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75600640 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75455482 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75087977 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75037694 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74359376 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73821233 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.72657288 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71918117 |
| 88 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71098109 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.69886922 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69254136 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69205951 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67720114 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66453451 |
| 94 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66146865 |
| 95 | Gap junction_Homo sapiens_hsa04540 | 0.66099485 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66096644 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66005804 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65900392 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.65875345 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65169243 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64602248 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.62827548 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.62746824 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.62588057 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62553471 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.62177228 |
| 107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62121691 |
| 108 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61683835 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.60949418 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60200743 |
| 111 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59589561 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57833300 |
| 113 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56964143 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56173921 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55859252 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.55762514 |
| 117 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55501542 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54546253 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53037295 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.52858929 |
| 121 | Long-term depression_Homo sapiens_hsa04730 | 0.52685778 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50466930 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.50371981 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50369214 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50149634 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50017249 |
| 127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49386297 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49042798 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48747081 |
| 130 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48405131 |
| 131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47750088 |
| 132 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47390423 |
| 133 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47109155 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46298587 |

